Azenta (AZTA) Capital Expenditures Growth (1y) (2011 - 2026)
Azenta (AZTA) Capital Expenditures Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.41 Bn | 121.19 Bn | 1.96 Bn | 17.46% |
| 2 | Becton Dickinson | 44.94 Bn | 44.13 Bn | 2.15 Bn | 9.65% |
| 3 | Alcon | 33.05 Bn | 31.39 Bn | 1.53 Bn | - |
| 4 | Medline | 32.82 Bn | 30.59 Bn | 1.84 Bn | -2.04% |
| 5 | Resmed | 29.45 Bn | 27.79 Bn | 890.98 Mn | 61.83% |
| 6 | West Pharmaceutical Services | 23.07 Bn | 22.63 Bn | 329.20 Mn | -42.55% |
| 7 | Solventum | 14.08 Bn | 13.52 Bn | 1.10 Bn | -22.94% |
| 8 | Cooper Companies | 13.86 Bn | 13.72 Bn | 735.40 Mn | 10.63% |
| 9 | Align Technology | 12.09 Bn | 11.03 Bn | 736.59 Mn | 21.73% |
| 10 | Azenta | 1.25 Bn | 1.02 Bn | 125.74 Mn | 83.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 83.52% |
| Dec 31, 2025 | -26.41% |
| Jun 30, 2025 | -57.90% |
| Mar 31, 2025 | 182.12% |
| Dec 31, 2024 | -31.36% |
| Sep 30, 2024 | -169.10% |
| Jun 30, 2024 | 18,228.87% |
| Mar 31, 2024 | 7.97% |
| Dec 31, 2023 | -12.08% |
| Sep 30, 2023 | 173.77% |
| Jun 30, 2023 | -100.92% |
| Mar 31, 2023 | -137.82% |
| Dec 31, 2022 | -30.24% |
| Sep 30, 2022 | -372.16% |
| Jun 30, 2022 | 69.74% |
| Mar 31, 2022 | 151.52% |
| Dec 31, 2021 | 20.90% |
| Sep 30, 2021 | 77.74% |
| Jun 30, 2021 | 6.58% |
| Mar 31, 2021 | -10.83% |